Literature DB >> 20556555

Dutasteride and prostate cancer risk.

Haim Matzkin1.   

Abstract

Entities:  

Year:  2010        PMID： 20556555     DOI： 10.1007/s11934-010-0129-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  6 in total

1.  Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.

Authors:  Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

2.  Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.

Authors:  Lynn N Thomas; C B Lazier; R Gupta; R W Norman; D A Troyer; S P O'Brien; R S Rittmaster
Journal:  Prostate       Date:  2005-05-15       Impact factor: 4.104

3.  Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.

Authors:  G L Andriole; C Roehrborn; C Schulman; K M Slawin; M Somerville; R S Rittmaster
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

4.  Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial.

Authors:  Gerald Andriole; David Bostwick; Otis Brawley; Leonard Gomella; Michael Marberger; Donald Tindall; Sharon Breed; Matt Somerville; Roger Rittmaster
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

5.  The influence of finasteride on the development of prostate cancer.

Authors:  Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2003-06-24       Impact factor: 91.245

6.  Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.

Authors:  Yael C Cohen; Kenneth S Liu; Norman L Heyden; Alexandra D Carides; Keaven M Anderson; Anastasia G Daifotis; Peter H Gann
Journal:  J Natl Cancer Inst       Date:  2007-09-11       Impact factor: 13.506
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.